Independent Director's Work Report for 2025 (Zhang Weidong)

Independent Director's Work Report for 2025

Dear shareholders and shareholder representatives:

As an independent director of China Resources Bo Ya Biopharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company"), I strictly adhered to the "Company Law of the People's Republic of China," "Securities Law of the People's Republic of China," "Self-Regulatory Guidelines No. 2 for Listed Companies on the Shenzhen Stock Exchange - Standardized Operations of GEM Listed Companies," "Management Measures for Independent Directors of Listed Companies," and other relevant laws and regulations, as well as the "Articles of Association" and "Independent Director Work System" requirements in 2025. I have consistently maintained an objective, independent, and fair stance, diligently fulfilling my duties, making prudent independent decisions, providing professional review opinions on significant matters, and effectively exercising the supervisory and professional support roles of independent directors and specialized committees. This has ensured the protection of the legitimate rights and interests of the Company and all shareholders, especially minority shareholders, while promoting standardized and efficient corporate governance. Below is my performance report for 2025:

I. Basic Information of the Independent Director

(1) Basic Information

I, Zhang Weidong, was born in 1963, hold Chinese nationality, and do not have permanent residency abroad. I have a doctoral degree. I previously served as the Vice Dean, Dean, Professor, and Doctoral Supervisor at the School of Accounting, Jiangxi University of Finance and Economics, enjoying special government allowances from the State Council and being selected for the "Ganpo Talent 555" project and the "New Century 1000-10,000 Talent Project" in Jiangxi Province. I have been recognized as a distinguished teacher in higher education in Jiangxi Province. I also serve as the Vice Chairman of the Financial Management Branch of the Chinese Accounting Society, a council member of the Chinese Auditing Society, and a member of the Legal Aid Committee of the Chinese Institute of Certified Public Accountants. Currently, I am an independent director of China Rare Earth Group Resource Technology Co., Ltd., TCL Zhonghuan Renewable Energy Technology Co., Ltd., and this Company. I have served as an independent director of the Company since February 3, 2021, and by the end of 2025, I will have completed five years of independent director duties.

(2) Independence Self-Assessment

I have completed the independence self-assessment as required by the regulators and confirmed that there are no circumstances affecting my independence as an independent director, in compliance with the "Management Measures for Independent Directors of Listed Companies" and other relevant regulations. The Company's board of directors has assessed my independence and found no issues that would hinder independent and objective judgment, confirming that I continue to meet the independence criteria for independent directors.

II. Annual Performance Overview of the Independent Director

(1) Attendance at Board and Shareholder Meetings

In 2025, I attended all 10 board meetings and 4 shareholder meetings, carefully reviewing materials before meetings, fully participating in discussions during meetings, and prudently exercising my voting rights, voting in favor of all proposals without any absences, opposition, or abstentions. The specific attendance is as follows: